Yesterday1 event
Today22 events
To consider and approve recommendations for increasing employee remuneration for FY 2026-27. Also, to discuss the finalization of accounts and commencement of various audits for FY 2025-26.
Intimation regarding NCLT order directing a meeting of equity shareholders to consider and approve the Composite Scheme of Arrangement.
To consider and approve the Initial Public Offering (IPO) of IFL Finance Limited, a subsidiary, and the re-appointment of an independent director.
To consider and approve audited financial results for the quarter and year ended March 31, 2026. The Board may also consider recommendation of final dividend.
To consider and take on record the Audited Financial Results for the year ended 31st March, 2026 and to recommend dividend, if any, on the equity shares of the Company.
To consider and approve the change of the company's name and consequent alteration in its Memorandum of Association and Articles of Association.
To consider and approve the Audited Financial Results (Standalone and Consolidated) for the quarter and year ended March 31, 2026.
To consider and approve audited standalone and consolidated financial results and dividend for the year ended on March 31, 2026.
To consider and approve the Audited Consolidated and Standalone Financial Results of the Bank for the quarter and financial year ended March 31, 2026. Also, to consider recommendation of dividend, if any, for the Financial Year 2025-26.
06 May 20269 events
To consider and approve the unaudited and audited financial results for the fourth quarter and financial year ended March 31, 2026. The board will also consider the recommendation of a final dividend for the year.
To consider and approve the sale, transfer, and disposal of land pertaining to the closed Textile Plant of the Company.
To consider increasing the authorized share capital and approve a material related party transaction for revision in project cost.
To consider and approve the audited financial results for the quarter and financial year ended 31 March 2026.
To consider and approve financial results for the quarter and year ended March 31, 2026, declare distributions to unitholders, and raise debt.
To consider and approve Audited Financial Results for the 4th quarter and financial year ended March 31, 2026, and to consider and recommend Final Dividend, if any.
To consider and approve the Audited Financial Results for the Quarter and Financial Year ended March 31, 2026, and to consider recommending Dividend, if any.
To consider and approve the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, and to consider the recommendation of dividend.
To consider and approve the unaudited (standalone & consolidated) financial results for the quarter and nine months ended 31st March, 2026.
To consider and approve standalone and consolidated audited financial results for the quarter and financial year ended March 31, 2026, and to consider recommendation of final dividend.
To take on record and approve the certificate issued by M/s. PAMS & Associates, Statutory Auditors, pursuant to Regulation 45(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015.
To consider increasing the authorized share capital and altering the capital and object clauses of the Memorandum of Association.
To consider and approve the Audited Standalone and Consolidated Financial Results for the quarter and financial year ending on March 31, 2026.
An Extra Ordinary General Meeting will be held to consider and pass a resolution to increase the authorised share capital of the company.
To consider and approve audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026, and to recommend dividend on equity shares.
To consider and approve standalone and consolidated financial results for the 4th Quarter and year ended March 31, 2026. Also, to consider declaring a dividend and fixing its record date.
To convene the 52nd Annual General Meeting to consider the Annual Report for the financial year ended December 31, 2025.
To convene the 35th Annual General Meeting and consider the Annual Report for the financial year ended December 31, 2025.